A carregar...

Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation

BACKGROUND: Hybrid therapy for atrial fibrillation class 1C and class III antiarrhythmic drugs (AAD) can convert atrial fibrillation (AF) into an isthmus-dependent atrial flutter (AFL) in more than 10% of patients. Hybrid pharmacological and ablative therapy offers a safe and effective approach to a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kimman, G.P., Szili-Torok, T., Nieuwdorp, M., Theuns, D.A.M.J., Scholten, M., Jordaens, L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2002
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2499668/
https://ncbi.nlm.nih.gov/pubmed/25696026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!